JPMorgan Chase & Co. 13D and 13G filings for Heron Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-12-07 2:45 pm Sale |
2023-11-30 | 13G | Heron Therapeutics, Inc. HRTX |
J P MORGAN CHASE & CO JPM |
84,549 0.000% |
-6,669,080 (-98.75%) |
Filing |
| 2023-01-23 12:34 pm Purchase |
2022-12-30 | 13G | Heron Therapeutics, Inc. HRTX |
J P MORGAN CHASE & CO JPM |
6,753,629 5.600% |
499,420 (+7.99%) |
Filing |
| 2022-01-24 12:02 pm Purchase |
2021-12-31 | 13G | Heron Therapeutics, Inc. HRTX |
J P MORGAN CHASE & CO JPM |
6,254,209 6.100% |
6,254,209 (New Position) |
Filing |